Reducing Drug Deaths in London

This report makes recommendations to the Mayor, Central Government and the Metropolitan Police Service (MPS) to help reduce the number of drug-related deaths across London and the UK.

Continue reading

Impacts of overdose: Evaluating the effects of grief and loss from overdose on people who inject drugs and developing an intervention to address them

Many people who inject drugs, and people who work in harm reduction services, are living with grief and loss stemming from the ongoing crisis of opioid-overdose related deaths. These experiences of loss can take a psychological toll, yet there are few bereavement services available for people with theses experiences.

Continue reading

Preventing overdose deaths in Europe

More than 9 000 lives were reported to be lost to drug overdoses in Europe (28 EU Member States, Turkey and Norway) in 2016, the latest reporting year, and this is an underestimate. Reducing drug-related deaths therefore remains a major challenge for public health policy. This analysis describes some of the factors that increase the risk of fatal and non-fatal overdoses and a number of interventions developed to prevent these events. Part of the ‘Perspectives on drugs’ (PODs) series, launched alongside the annual European Drug Report, these designed-for-the-web interactive analyses aim to provide deeper insights into a selection of important issues.

Continue reading

National Naloxone Programme Scotland: Monitoring Report 2017/18

Since the beginning of the National Naloxone Programme, the Scottish Government has commissioned Information Services Division (ISD) to report on THN kit distribution using monitoring data supplied by NHS Boards. This report presents information on the number of THN kits issued from 2011/12 to 2017/18. Data are presented separately for kits issued from community outlets, kits issued in prisons at the point of prisoner release and kits dispensed via community prescription. The number and percentage of opioid-related deaths that occurred within four or twelve weeks of prison release or hospital discharge are also presented.

Continue reading

This website has been made possible through the provision of an arm length/unrestricted educational grant from Ethypharm. Ethypharm do not control and are not liable for any of the content placed, or any of the claims that may be made, on this site.

HIT